// App-Quantinova.ai

86 : First Presentation of Inflammatory Bowel Disease as a Migratory Polyarthritis with Positive C-ANCA and PR3

Researchers

Presenter

  • Ibrahim Almaghlouth

Principal Investigators

  • Zahi Touma

Medical Centers

  • Division of Rheumatology, Department of Medicine, Toronto Western Hospital, University of Toronto, Toronto,Canada

  • Univ of Toronto, Toronto, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Leukocytoclastic vasculitis

  • Inflammatory bowel disease

  • Ulcerative colitis

  • Erythema nodosum leprosum

  • Inflammatory Arthritis

  • Hematoma

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • C reactive protein

  • Progesterone receptor

  • Cluster of differentiation 79A

  • Estrogen receptor alpha

  • Ubiquitin A-52 Residue Ribosomal Protein Fusion Product 1

Drug/Treatment

  • Prednisone

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved